Roman Butler Fullerton & CO Abb Vie Inc. Transaction History

Roman Butler Fullerton & CO

$334 Million
Q3 2024

A detailed history of Roman Butler Fullerton & CO transactions in Abb Vie Inc. stock. As of the latest transaction made, Roman Butler Fullerton & CO holds 4,761 shares of ABBV stock, worth $834,984. This represents 0.28% of its overall portfolio holdings.

Number of Shares

4,761

Previous 4,752 0.19%

Holding current value

$834,984

Previous $815,000 15.34%

% of portfolio

0.28%

Previous 0.28%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$163.84 - $199.33 $1,474 - $1,793	9 Added 0.19%	4,761 $940,000
Q2 2024 Jul 15, 2024	BUY	$154.79 - $180.76 $1,083 - $1,265	7 Added 0.15%	4,752 $815,000
Q1 2024 Apr 29, 2024	BUY	$159.82 - $182.1 $17,420 - $19,848	109 Added 2.35%	4,745 $864,000
Q4 2023 Jan 31, 2024	SELL	$137.6 - $154.97 $8,118 - $9,143	-59 Reduced 1.26%	4,636 $718,000
Q3 2023 Oct 18, 2023	BUY	$133.59 - $154.65 $14,828 - $17,166	111 Added 2.42%	4,695 $699,000
Q2 2023 Jul 25, 2023	BUY	$132.51 - $164.9 $54,196 - $67,444	409 Added 9.8%	4,584 $617,000
Q1 2023 Apr 27, 2023	BUY	$144.61 - $166.54 $17,063 - $19,651	118 Added 2.91%	4,175 $665,000
Q4 2022 Jan 23, 2023	BUY	$138.31 - $165.87 $2,489 - $2,985	18 Added 0.45%	4,057 $0
Q3 2022 Oct 17, 2022	BUY	$134.21 - $153.93 $1,073 - $1,231	8 Added 0.2%	4,039 $572,000
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $14,174 - $18,020	-103 Reduced 2.49%	4,031 $619,000
Q1 2022 May 05, 2022	BUY	$131.98 - $163.75 $659 - $818	5 Added 0.12%	4,134 $670,000
Q4 2021 Jan 24, 2022	BUY	$107.43 - $135.93 $1,504 - $1,903	14 Added 0.34%	4,129 $559,000
Q2 2021 Jul 29, 2021	BUY	$105.21 - $117.21 $24,934 - $27,778	237 Added 6.11%	4,115 $464,000
Q4 2020 Feb 01, 2021	SELL	$80.49 - $108.67 $31,471 - $42,489	-391 Reduced 9.16%	3,878 $416,000
Q3 2020 Oct 15, 2020	SELL	$85.91 - $100.83 $16,408 - $19,258	-191 Reduced 4.28%	4,269 $374,000
Q2 2020 Jul 28, 2020	BUY	$73.37 - $98.18 $73,956 - $98,965	1,008 Added 29.2%	4,460 $438,000
Q1 2020 Apr 13, 2020	SELL	$64.5 - $97.79 $38,248 - $57,989	-593 Reduced 14.66%	3,452 $263,000
Q4 2019 Jan 27, 2020	BUY	$72.13 - $90.25 $22,216 - $27,797	308 Added 8.24%	4,045 $358,000
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $33,883 - $40,737	-538 Reduced 12.58%	3,737 $283,000
Q2 2019 Jul 22, 2019	BUY	$65.7 - $83.98 $29,827 - $38,126	454 Added 11.88%	4,275 $311,000
Q1 2019 Apr 24, 2019	BUY	$77.14 - $90.79 $43,275 - $50,933	561 Added 17.21%	3,821 $308,000
Q4 2018 Feb 04, 2019	BUY	$77.85 - $96.01 $253,790 - $312,992	3,260 New	3,260 $288,000

Others Institutions Holding ABBV

# of Institutions

3,852

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Roman Butler Fullerton & CO, based on Form 13F filings with the SEC.

News

Stay updated on Roman Butler Fullerton & CO with notifications on news.

Account

Roman Butler Fullerton & CO Abb Vie Inc. Transaction History